Based on previous and current findings in the field, a model is emerging in which diffuse axonal injury, Tau pathology, and neuroinflammation incrementally contribute to long-term changes in the brain that eventually lead to increased risk for tauopathies such as AD or CTE with aging. The gene discussed is MAPT; the disease is Alzheimer disease.